Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Other Non-Current Liabilities (2020 - 2025)

Cellebrite DI (CLBT) has 6 years of Other Non-Current Liabilities data on record, last reported at $16.7 million in Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 139.82% year-over-year to $16.7 million; the TTM value through Dec 2025 reached $16.7 million, up 139.82%, while the annual FY2025 figure was $16.7 million, 139.82% up from the prior year.
  • Other Non-Current Liabilities reached $16.7 million in Q4 2025 per CLBT's latest filing, up from $7.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $56.5 million in Q4 2021 and bottomed at $5.4 million in Q4 2022.
  • Average Other Non-Current Liabilities over 5 years is $27.9 million, with a median of $16.7 million recorded in 2025.
  • Peak YoY movement for Other Non-Current Liabilities: crashed 90.45% in 2022, then surged 903.28% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $56.5 million in 2021, then plummeted by 90.45% to $5.4 million in 2022, then soared by 903.28% to $54.1 million in 2023, then crashed by 87.15% to $7.0 million in 2024, then surged by 139.82% to $16.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $16.7 million in Q4 2025, $7.0 million in Q4 2024, and $54.1 million in Q4 2023.